Flowers Lee's Form 4 filing
HCW Biologics Inc. (HCWB) · filed Aug 24, 2021
- Accession no.
- 0001209191-21-053170
- Filed
- Aug 24, 2021
- Trade date
- Aug 20-23, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $54.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flowers LeeCIK 0001866254 | Officer (SVP of Business Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2021 | Common Stock | PPurchaseAcquired | +7,853 | $4.08F1 | +$32,040.24 | 86,062 | Direct | |
| Aug 23, 2021 | Common Stock | PPurchaseAcquired | +5,605 | $3.95 | +$22,139.75 | 91,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The range of prices for the shares of Common Stock is from $4.06 to $4.166. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
Referenced by the price of 1 transaction in Table I.